NDC 63323-047-01 - Heparin Sodium

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 63323-047
Requested NDC: 63323-047-01
Package NDCs from labels: 63323-047-01, 63323-047-10
Manufacturer: Fresenius Kabi USA, LLC
Effective date: 2025-11-28
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Heparin Sodium - Fresenius Kabi USA, LLC	Fresenius Kabi USA, LLC	2025-11-28	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
63323-047-01	Heparin Sodium	10 mL in 1 VIAL	INJECTION, SOLUTION	10		13
63323-047-10	Heparin Sodium	25 in 1 TRAY	INJECTION, SOLUTION	25		13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63323-047	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	12	Current NDC, Legacy NDC, 2 package rows	20241017_d55b4a63-0c04-4874-b74f-9e9b9e8b008c.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63323-047-01	ML - Milliliter	63323-047	3c7fe6df-fb98-4356-bce7-00d4fbdd307f	1	2022-03-09
63323-047-10	ML - Milliliter	63323-047	2b4385e4-7fbb-450e-9620-6748a96f842e	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
HEPARIN SODIUM	ACTIVE INGREDIENT	ZZ45AB24CA	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	9
HEPARIN	ACTIVE MOIETY	T2410KM04A	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	9
BENZYL ALCOHOL	INACTIVE INGREDIENT	LKG8494WBH	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	9
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	9
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	9
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	9
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	9
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	9

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 47 of 47 · 924 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Join
SODIUM CHLORIDE	SODIUM CHLORIDE	Baxter Healthcare Corporation	b3b4b176-41f0-4ca8-90d4-3fba5707564a	2014-02-21	Exact identifier unii: 451W47IQ8X
TIS-U-SOL	SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM PHOSPHATE, AND POTASSIUM PHOSPHATE	Baxter Healthcare Corporation	9da4121f-d62d-4da4-8dfb-0494da16015f	2014-02-21	Exact identifier unii: 451W47IQ8X
Ringers	SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE,	Baxter Healthcare Corporation	e1953d54-818d-46a6-8532-518ebae6d84e	2012-06-13	Exact identifier unii: 451W47IQ8X
Lactated Ringers	SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE	Baxter Healthcare Corporation	f09f80bf-2f8b-4420-865d-aec2d5e5cd4d	2012-06-12	Exact identifier unii: 451W47IQ8X

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.